The main components in sodium rabeprazole azole enteric-coated metformin hydrochloride rabeprazole azole sodium. Chemical name: 2 - {[4 - (3 - methoxy c oxygen radicals) - 3 - methyl pyridine and 2 - base] methylene sulfonyl} - 1 h - sodium benzene and imidazole. , then taking rabeprazole sodium enteric-coated metformin hydrochloride can appear the symptom of pharyngitis?

Rabeprazole azole sodium enteric-coated metformin hydrochloride for the enteric coating, after removing the coating show white. Rabeprazole azole sodium enteric-coated metformin hydrochloride used in active duodenal ulcer; Benign active gastric ulcer; Aggressive with clinical symptoms or ulcer of stomach esophagus regurgitation (GORD). Rabeprazole azole sodium enteric-coated metformin hydrochloride with the appropriate antibiotics, can effect a radical cure helicobacter pylori positive duodenal ulcer. Rabeprazole azole sodium enteric-coated metformin hydrochloride used in corrosive or ulcerative gastric esophagus regurgitation maintenance period of treatment. Is to evaluate the efficacy of treatment more than 12 months has not yet.

Rabeprazole azole sodium enteric-coated metformin hydrochloride for benzene compounds and imidazoles, rabeprazole azole sodium enteric-coated metformin hydrochloride is the second generation of proton pump inhibitors, rabeprazole azole sodium enteric-coated metformin hydrochloride through specific inhibition of parietal cell H +, K + atpase system and block the last step of gastric acid secretion. The effect of sodium rabeprazole azole enteric-coated metformin hydrochloride in dose dependent, and can make gastric acid secretion of gastric acid secretion and stimulated the basis of inhibition. Rabeprazole azole sodium enteric-coated metformin hydrochloride is for choline and histamine H2 receptor antagonist.

Rabeprazole azole sodium enteric-coated metformin hydrochloride in oral rabeprazole sodium azole within one hour after 20 mg play efficacy, rabeprazole azole sodium enteric-coated metformin hydrochloride in blood drug concentration up to 2 ~ 4 hours peak, rabeprazole azole sodium enteric-coated metformin hydrochloride in the first time in 23 hours after inhibits gastric acid amount and amount of hydrochloric acid in gastric juice produced by food stimulation, inhibition rate were 69% and 82% respectively, and the time up to 48 hours, rabeprazole effect time of sodium enteric-coated metformin hydrochloride significantly longer than the half-life of pharmacokinetic (about 1 hour). The mechanism of action of rabeprazole azole sodium enteric-coated metformin hydrochloride to curb H [sup] + [/ sup] / K + atpase. Rabeprazole azole sodium enteric-coated metformin hydrochloride on the inhibition of gastric acid secretion increases with dose can slightly increase, but three days later can reach stable level. Even after the drug withdrawal, this also can maintain stable level 2 ~ 3 days.

Rabeprazole azole sodium enteric-coated metformin hydrochloride is the most common adverse reactions as a headache, diarrhea and nausea. Other adverse reactions have rhinitis, abdominal pain, weakness, gastric bowel to bilge gas, pharyngitis, vomiting, nonspecific pain or back pain, dizziness, flu symptoms, infectious cough, constipation and insomnia.

Saw the above introduction, believe everybody already knows taking Bella azole sodium enteric-coated metformin hydrochloride can appear the symptom of pharyngitis, if necessary, consult the thunder Bella azole sodium manufacturer sales staff, must be able to solve your problem. Hope these information can help to you.

, keywords: rabeprazole azole sodium rabeprazole sodium manufacturers